BC tissues; normal paracancerous tissue samples; normal bladder tissues
T24; UM-UC-3; 5637; J82
cell line-derived xenograft
proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); ceRNA regulation (promotes); MAPK/ERK (promotes)
Microarray; RT-qPCR; Clinical Sample Validation; Luciferase Reporter Assay; Bioinformatics Analysis; Transfection; CCK8; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Wound Healing Assay; Western Blot; In Vivo Animal Model
High circFARSA expression is associated with more advanced tumor stage, larger tumor size, higher grade, and lymph node metastasis in bladder cancer patients.
circFARSA is up-regulated in bladder cancer tissues and cell lines and promotes malignant phenotypes (proliferation, migration/invasion) while inhibiting apoptosis. Mechanistically, it acts as a ceRNA by sponging miR-330-5p, thereby increasing downstream oncogenic proteins such as MAPK/ERK, SIRT6, ITGA5, PAK1, MUC1 and NOB1, and its knockdown suppresses tumor growth in a T24 xenograft model.
0.6837
The circular RNA circFARSA sponges microRNA-330-5p in tumor cells with bladder cancer phenotype.
combined biological and clinical study